| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Candel Therapeutics, Inc. | Director | Common Stock | 2,141 | $9,998 | $4.67 | 25 Jun 2025 | Direct |
| Candel Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,240 | 17 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | 25 Jun 2025 | 1 | +$9,998 | 4 | Director | 26 Jun 2025, 08:30 |
| CADL | Candel Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 08:36 |
| CADL | Candel Therapeutics, Inc. | 26 Jun 2024 | 1 | $0 | 4 | Director | 27 Jun 2024, 08:36 |
| CADL | Candel Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 08:45 |
| CADL | Candel Therapeutics, Inc. | 07 Jun 2023 | 0 | $0 | 3 | Director | 09 Jun 2023, 08:30 |